Luven v. Soon-Shiong et al

Track this case

Case Number:

3:24-cv-02014

Court:

California Southern

Nature of Suit:

Stockholders Suits

Multi Party Litigation:

Derivative Litigation

Judge:

Gonzalo P. Curiel

Firms

  1. July 30, 2025

    ImmunityBio Investors Nab Initial OK On Derivative Suit Deal

    A California federal judge has granted initial approval to a deal ending derivative claims that ImmunityBio executives failed to disclose manufacturing deficiencies that doomed the company's lead cancer drug application.

  2. October 30, 2024

    LA Times Owner Faces Investor Suit Over Drug Co.'s Woes

    Officers and directors of biotechnology company ImmunityBio Inc., including L.A. Times owner Patrick Soon-Shiong, face a shareholder's derivative complaint alleging the company concealed issues affecting a path to regulatory approval for one of its key product candidates.